 <h1>Gattex Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>teduglutide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about teduglutide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Gattex.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to teduglutide: subcutaneous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, teduglutide (the active ingredient contained in Gattex) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking teduglutide:</p><p>
<i>More common</i>
</p><ul>
<li>Decrease in the amount of urine</li>
<li>excess air or gas in the stomach or bowels</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>full or bloated feeling</li>
<li>hives, itching, skin rash</li>
<li>hoarseness</li>
<li>irritation</li>
<li>joint pain, stiffness, or swelling</li>
<li>noisy, rattling breathing</li>
<li>pressure in the stomach</li>
<li>redness of the skin</li>
<li>stomach pain</li>
<li>swelling of the abdominal or stomach area</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>tightness in the chest</li>
<li>troubled breathing at rest</li>
<li>troubled breathing or swallowing</li>
<li>weight gain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Indigestion</li>
<li>severe nausea or vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blurred vision</li>
<li>chest pain or discomfort</li>
<li>dilated neck veins</li>
<li>extreme tiredness or weakness</li>
<li>inability to speak</li>
<li>irregular breathing</li>
<li>irregular heartbeat</li>
<li>loss of consciousness</li>
<li>no blood pressure or pulse</li>
<li>seizures</li>
<li>severe or sudden headache</li>
<li>slurred speech</li>
<li>stopping of the heart</li>
<li>temporary blindness</li>
<li>weakness in the arm or leg on one side of the body, sudden and severe</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of teduglutide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>changes in appetite</li>
<li>chills</li>
<li>cough</li>
<li>ear congestion</li>
<li>headache</li>
<li>loss of voice</li>
<li>nausea</li>
<li>runny or stuffy nose</li>
<li>sneezing</li>
<li>sore throat</li>
<li>trouble sleeping</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<!-- end subcutaneous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to teduglutide: subcutaneous kit</i></p><h3>General</h3><p>The most commonly reported side effects included antibody formation, abdominal distention, abdominal pain, and gastrointestinal stoma complications (in patients with a stoma).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal distention (up to 45%), abdominal pain (up to 45%), gastrointestinal (GI) stoma complications (up to 42%), nausea (up to 26%), vomiting (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Colonic polyp, colonic stenosis, colorectal polyp, diarrhea, flatulence, intestinal obstruction, pancreatic duct stenosis, pancreatitis, small intestinal stenosis, upper abdominal pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Duodenal polyp</p>
<p><b>Frequency not reported</b>: Abdominal wall hematoma, acute pancreatitis, chronic pancreatitis, gastric polyp, pancreatic disease, pancreatic pseudocyst<sup>[Ref]</sup></p><p>GI stoma complication (swelling of the stoma and associated complications) is considered a sign of efficacy rather than an adverse event.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Respiratory tract infections (up to 28%), upper respiratory tract reaction (up to 21%), nasopharyngitis (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Cough, dyspnea</p>
<p><b>Frequency not reported</b>: Laryngitis, lower respiratory tract infection, pharyngitis, rhinitis, sinusitis, viral upper respiratory infection<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (up to 26%), injection site hematoma (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Injection site erythema</p>
<p><b>Frequency not reported</b>: Injection site discoloration, injection site hemorrhage, injection site pain, injection site rash, injection site swelling<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Antibody formation (up to 54%)</p>
<p><b>Common</b> (1% to 10%): Catheter related infection, catheter sepsis, influenza, influenza-like illness<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (up to 13%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Fluid overload (up to 12%)</p>
<p><b>Common</b> (1% to 10%): Decreased appetite</p>
<p><b>Frequency not reported</b>: Fluid imbalance, fluid retention<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, insomnia, sleep disturbance<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Congestive heart failure, peripheral edema</p>
<p><b>Frequency not reported</b>: Edema, flushing, generalized edema, hematoma, jugular vein distention, post-procedural hematoma<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Acute cholecystitis, cholecystitis</p>
<p><b>Frequency not reported</b>: Biliary disease, cholelithiasis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, pyrexia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Skin hemorrhage</p>
<p><b>Frequency not reported</b>: Allergic dermatitis, blood blister, drug eruption, erythema, pruritus, macular rash, rash, umbilical hematoma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia</p>
<p><b>Frequency not reported</b>: Hypersomnia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Acceleration of neoplastic growth, metastatic adenocarcinoma, lung cancers (squamous and non-small cell)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Eyelid edema<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Increased c-reactive protein<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Gattex (teduglutide)." NPS Pharmaceuticals, Bedminster, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Gattex (teduglutide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous GI agents</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gattex &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Short Bowel Syndrome</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to teduglutide: subcutaneous kit</i></p><h3>General</h3><p>The most commonly reported side effects included antibody formation, abdominal distention, abdominal pain, and gastrointestinal stoma complications (in patients with a stoma).<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal distention (up to 45%), abdominal pain (up to 45%), gastrointestinal (GI) stoma complications (up to 42%), nausea (up to 26%), vomiting (up to 14%)</p><p><b>Common</b> (1% to 10%): Colonic polyp, colonic stenosis, colorectal polyp, diarrhea, flatulence, intestinal obstruction, pancreatic duct stenosis, pancreatitis, small intestinal stenosis, upper abdominal pain</p><p><b>Uncommon</b> (0.1% to 1%): Duodenal polyp</p><p><b>Frequency not reported</b>: Abdominal wall hematoma, acute pancreatitis, chronic pancreatitis, gastric polyp, pancreatic disease, pancreatic pseudocyst<sup>[Ref]</sup></p><p>GI stoma complication (swelling of the stoma and associated complications) is considered a sign of efficacy rather than an adverse event.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Respiratory tract infections (up to 28%), upper respiratory tract reaction (up to 21%), nasopharyngitis (up to 13%)</p><p><b>Common</b> (1% to 10%): Cough, dyspnea</p><p><b>Frequency not reported</b>: Laryngitis, lower respiratory tract infection, pharyngitis, rhinitis, sinusitis, viral upper respiratory infection<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (up to 26%), injection site hematoma (up to 11%)</p><p><b>Common</b> (1% to 10%): Injection site erythema</p><p><b>Frequency not reported</b>: Injection site discoloration, injection site hemorrhage, injection site pain, injection site rash, injection site swelling<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Antibody formation (up to 54%)</p><p><b>Common</b> (1% to 10%): Catheter related infection, catheter sepsis, influenza, influenza-like illness<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 16%)</p><p><b>Uncommon</b> (0.1% to 1%): Syncope<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection (up to 13%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Fluid overload (up to 12%)</p><p><b>Common</b> (1% to 10%): Decreased appetite</p><p><b>Frequency not reported</b>: Fluid imbalance, fluid retention<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, insomnia, sleep disturbance<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Congestive heart failure, peripheral edema</p><p><b>Frequency not reported</b>: Edema, flushing, generalized edema, hematoma, jugular vein distention, post-procedural hematoma<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Acute cholecystitis, cholecystitis</p><p><b>Frequency not reported</b>: Biliary disease, cholelithiasis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, pyrexia<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Skin hemorrhage</p><p><b>Frequency not reported</b>: Allergic dermatitis, blood blister, drug eruption, erythema, pruritus, macular rash, rash, umbilical hematoma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Arthralgia</p><p><b>Frequency not reported</b>: Hypersomnia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Frequency not reported</b>: Acceleration of neoplastic growth, metastatic adenocarcinoma, lung cancers (squamous and non-small cell)<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Eyelid edema<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Frequency not reported</b>: Increased c-reactive protein<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Gattex (teduglutide)." NPS Pharmaceuticals, Bedminster, NJ. </p><p id="ref_3">3. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2>More about Gattex (teduglutide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>Drug class: miscellaneous GI agents</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gattex &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Short Bowel Syndrome</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>